Q1 2024 Laboratory & Testing Report
An in-depth look at the Laboratory & Testing Services sector for Q1, 2024, where Mirus’ partners apply their expertise and experience to take a closer look at news, transactions, and state of the industry.
The Mirus team has worked with the owners of closely-held companies in multiple segments of the $2.8 trillion US healthcare industry. We benefit from being in the hub of healthcare investing in the US – with one of the most active venture capital communities, global pharmaceutical research centers and leading universities, large medical device companies and innovative med-tech and healthcare services firms.
Healthcare is an active area for M&A and an attractive segment for private equity investing, capturing between 10% and 20% of total global private equity investing each year. The Mirus healthcare team has experience raising capital for growing healthcare businesses and experience in strategic M&A with some of the largest healthcare companies in the industry. We have expertise in all facets of the healthcare market, including:
Mirus provides direct access to sector-specific expertise, as well as knowledge of, access to and relationships with global buyers and sellers in the healthcare sector.
An in-depth look at the Laboratory & Testing Services sector for Q1, 2024, where Mirus’ partners apply their expertise and experience to take a closer look at news, transactions, and state of the industry.